ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,107.60
-0.05%
Dow Jones
39,721.36
1.09%
Brent Oil
84.88
-0.20%
Bitcoin
58,225.22
0.81%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
05/07/20204:03AMDow Jones NewsGlaxoSmithKline to Raise INR254.8 Billion via Sale of Hindustan Unilever StockNYSE:GSKGSK plc
04/29/20204:13PMPR Newswire (US)FDA approves Zejula (niraparib) as the only once-daily PARP inhibitor in first-line monotherapy maintenance treatment for wom...NYSE:GSKGSK plc
04/29/202011:33AMDow Jones NewsGlaxo Unit Recalls Some Benefiber Lots Due to Plastic ContaminationNYSE:GSKGSK plc
04/29/20209:17AMDow Jones NewsGlaxoSmithKline 1Q Beats Forecasts -- Earnings ReviewNYSE:GSKGSK plc
04/29/20207:53AMDow Jones NewsGlaxoSmithKline 1Q Earnings Beat Forecasts; Backs 2020 ViewNYSE:GSKGSK plc
04/23/20208:03PMBusiness WireGSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent ...NYSE:GSKGSK plc
04/14/20208:44PMDow Jones NewsCorrection to GlaxoSmithKline ArticleNYSE:GSKGSK plc
04/14/202011:14AMDow Jones NewsGlaxoSmithKline, Sanofi Team Up for Coronavirus VaccineNYSE:GSKGSK plc
04/14/20207:29AMDow Jones NewsGlaxoSmithKline, Sanofi Join Forces to Develop Coronavirus VaccineNYSE:GSKGSK plc
04/13/20203:46PMPR Newswire (US)Voltaren Arthritis Pain and the Arthritis Foundation Announce Multi-Year Partnership to Help People Living with Osteoarthriti...NYSE:GSKGSK plc
04/07/20209:30AMDow Jones NewsGSK, AstraZeneca Partner to Tackle Covid-19 Test ShortagesNYSE:GSKGSK plc
04/06/20208:49AMDow Jones NewsGlaxoSmithKline to Invest $250 Million in Vir Biotechnology Inc.NYSE:GSKGSK plc
04/06/20208:01AMGlobeNewswire Inc.GSK and Vir Biotechnology enter collaboration to find coronavirus solutionsNYSE:GSKGSK plc
03/16/20208:21AMDow Jones NewsZai Lab Says China Supplemental New Drug Application for Zejula AcceptedNYSE:GSKGSK plc
03/10/20209:54AMDow Jones NewsAgenus Gets $15.1 Million Milestone Payment for Shingrix SalesNYSE:GSKGSK plc
02/28/20205:38PMPR Newswire (US)FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United StatesNYSE:GSKGSK plc
02/24/20209:56AMDow Jones NewsGlaxoSmithKline Says FDA Accepts SNDA Application for ZejulaNYSE:GSKGSK plc
02/24/20207:46AMDow Jones NewsSwitzerland's Stada Buys 15 Consumer Brands From GlaxoSmithKLineNYSE:GSKGSK plc
02/20/20205:29AMDow Jones NewsGlaxoSmithKline Invests $50 Million in Biotech Startup's Cell-Therapy ProgramNYSE:GSKGSK plc
02/17/202010:00AMPR Newswire (US)FDA approves GSK's Voltaren Arthritis Pain for over-the-counter use in the United StatesNYSE:GSKGSK plc
02/06/20203:02AMDow Jones NewsMerck to Spin Off $6.5 Billion In Products -- WSJNYSE:GSKGSK plc
02/05/20209:58AMDow Jones NewsGlaxoSmithKline Comes Short of Forecasts But Maintains Dividend -- Earnings ReviewNYSE:GSKGSK plc
02/05/20209:08AMDow Jones NewsGlaxoSmithKline Steps Up Research in Preparation of Consumer Health Split -- UpdateNYSE:GSKGSK plc
02/05/20207:58AMDow Jones NewsGlaxoSmithKline 4Q Pretax Profit Rose But Sees Falling Earnings in 2020NYSE:GSKGSK plc
02/05/20207:14AMDow Jones NewsMerck to Spin Off Slow-Growth Products Into New CompanyNYSE:GSKGSK plc
02/03/20204:00AMPR Newswire (US)GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the t...NYSE:GSKGSK plc
02/02/20207:41PMDow Jones NewsGlaxoSmithKline Offers Vaccine Booster to Research GroupsNYSE:GSKGSK plc
01/28/202011:00AMPR Newswire (US)TUMS game day sweepstakesNYSE:GSKGSK plc
01/21/202010:53AMDow Jones NewsGlaxoSmithKline Gets FDA Priority Review of Belantamab Mafodotin in Multiple MyelomaNYSE:GSKGSK plc
01/21/20209:00AMPR Newswire (US)US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory...NYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
SFRX
Seafarer Exploration (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
USOTC
RONN
Ronn Motor (PK)
NASDAQ
FCEL
FuelCell Energy
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
AXXA
Exxe (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
RNVA
Rennova Health (PK)
AMEX
SPY
SPDR S&P 500
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved